Dianthus Therapeutics Ownership | Who Owns Dianthus Therapeutics?
Dianthus Therapeutics Ownership Summary
Dianthus Therapeutics is owned by 47.55% institutional investors, and 52.45% retail investors. Vanguard Instl Ttl Stck Mkt Idx Tr is the top mutual fund, with 2.36% of its assets in Dianthus Therapeutics shares.
Institutional Shareholders
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2023 | 43 | -15.69% | 28,834,243 | -2.22% | 47 | 2.01% | 13 | -45.83% | 11 | 10.00% |
| Mar 31, 2023 | 51 | -1.92% | 29,489,573 | 5.49% | 48 | 2.19% | 24 | 4.35% | 10 | -28.57% |
| Dec 31, 2022 | 52 | -22.39% | 27,955,148 | -39.79% | 47 | 0.77% | 23 | 4.55% | 14 | -41.67% |
| Sep 30, 2022 | 67 | -5.63% | 46,426,800 | 2.18% | 78 | 1.31% | 22 | -35.29% | 24 | 33.33% |
| Jun 30, 2022 | 71 | -15.48% | 45,438,307 | -5.04% | 77 | 1.17% | 34 | 6.25% | 18 | -35.71% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Instl Ttl Stck Mkt Idx Tr | 1.43M | 2.36% | - |
| Fidelity® Series Small Cap Opps | 429.68K | 0.71% | - |
| Fidelity® Stock Selector Small Cap | 193.10K | 0.32% | - |
| Fidelity® Extended Market Index | 190.58K | 0.31% | - |
| Fidelity® Total Market Index | 49.50K | 0.08% | - |
| Fidelity® Series Total Market Index | 47.84K | 0.08% | - |
| Fidelity® NASDAQ Composite Index® | 44.60K | 0.07% | - |
| Schwab Total Stock Market Index | 27.37K | 0.05% | - |
| SSgA U.S. Extended Market Index Class I | 11.80K | 0.02% | - |
| SSgA U.S. Total Market Index Strategy | 3.71K | 0.01% | -10.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 29, 2023 | Fairmount Funds Management LLC | Buy | $336.25K | |
| Sep 26, 2023 | Fairmount Funds Management LLC | Buy | $394.50K | |
| Sep 22, 2023 | Randhawa Simrat | Chief Medical Officer | Buy | $26.40K |
| Sep 21, 2023 | Randhawa Simrat | Chief Medical Officer | Buy | $26.40K |
| Sep 19, 2023 | Fairmount Funds Management LLC | Buy | $396.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2023 Q3 | 6 | - |
| 2023 Q1 | - | 2 |
| 2022 Q4 | - | - |
| 2022 Q3 | - | - |
| 2022 Q2 | - | - |
MGTA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools